Trial Profile
Effect of the DPP-4 Inhibitor, Vildagliptin, on Gastric Accommodation and Food Intake in Humans
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Sep 2022
Price :
$35
*
At a glance
- Drugs Vildagliptin (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 03 Mar 2019 Results evaluating the effect of vildagliptin on gastric accommodation and ad libitum food intake in healthy volunteers published in the Alimentary Pharmacology and Therapeutics
- 20 Apr 2018 New trial record